No Detail Found!

Hospitalized COVID-19 Patients Characteristics, Comorbidities, and Outcomes: A Retrospective Study

Author(s)
Farooq Ahmed Wani Department of Pathology, College of Medicine, Jouf University,Sakaka,Saudi Arabia
Ashokkumar Thirunavukkarasu Department of Community Medicine, College of Medicine, Jouf University,Sakaka,Saudi Arabia
Nawaf Abdulaziz Alzarea College of Medicine, Jouf University, Sakaka, Saudi Arabia
Waleed Abdullah Alzarea College of Medicine, Jouf University, Sakaka, Saudi Arabia
Omar Mohammed Alshaya College of Medicine, Jouf University, Sakaka, Saudi Arabia
Abdulkarim Fihat B Alanazi College of Medicine, Jouf University, Sakaka, Saudi Arabia
Abdelazeez Mefreh Aldeghmani College of Medicine, Jouf University, Sakaka, Saudi Arabia
Layth Dhumayri Alruwaili College of Medicine, Jouf University, Sakaka, Saudi Arabia
Muhannad Aldayri Yatim Alruwaili College of Medicine, Jouf University, Sakaka, Saudi Arabia
Abdulsalam Hail Fandi Alruwaili College of Medicine, Jouf University, Sakaka, Saudi Arabia
Abstract
The current research aimed to evaluate the hospitalized COVID-19 Patients' characteristics, comorbidities, and outcomes. The present hospital-based study was executed in the COVID-19 units of Aljouf province. A simple random sampling method was applied to include the 400 patients' files and all the relevant data was collected. The association between the COVID-19 outcome with sociodemographic characteristics, comorbidities, and immune status was assessed using the chi-square test. A p-value <0.05 was taken as statistically significant. The common symptoms were fever (54.5%), followed by cough (47.8%), and shortness of breath (47.3%). The commonest comorbidity was diabetes mellitus (43.5%). Of the 400 patients, 77.3% had recovered without any complications, 4.5% had one or more complications, and mortality was 18.3%. The COVID-19 outcome (complete recovery, recovery with complications, and death) were significantly associated with age (p<0.001), immune status (p=0.001), diabetes (p=0.001), hypertension (p=0.001), IHD (p=0.025), CKD (p=0.001), and cardiac failure (p=0.008). Most of the patients (77.3%) recovered completely and a mortality rate of 18.3% was observed in our study. This study confirms that patients afflicted with co-morbid conditions like diabetes, hypertension, IHD, CKD, and cardiac failure are highly susceptible to poor outcomes.
Publication Details
Page(s) 70-76
Published Journal: Archives of Pharmacy Practice, Volume: 14, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Disease, Coronavirus, Infections, vaccination
0

Citations

0

Downloads

41

Views